Literature DB >> 18560264

The many faces of pheochromocytoma.

H K Ghayee1, K L Wyne, F S Yau, W H Snyder, S Holt, S Tunc Gokaslan, F Nwariaku.   

Abstract

OBJECTIVE: To recognize and manage pheochromocytomas in unusual settings.
METHODS: Three case reports are presented with clinical, biochemical, imaging, and operative findings. The pitfalls in diagnosis of pheochromocytomas and management are addressed.
RESULTS: We begin with a 27-yr-old gravida 2, para 1 Caucasian woman with unexplained tachycardia and hypertension during a routine pre-natal visit at 30 weeks estimated gestational age. Urinary studies revealed elevated catecholamines. Magnetic resonance imaging localized a 6.6-cm right adrenal mass with features consistent with a pheochromocytoma. She was medically managed with phenoxybenzamine and propranolol until 35 weeks, after which she underwent a combined Cesarean section, and open right adrenalectomy. Another patient, a 36-yr-old African-American woman presented to a hospital in cardiac arrest, with elevated serum troponins, and underwent cardiac catheterization, which revealed normal coronary arteries. A computed tomography (CT) scan revealed a left adrenal mass and CT-guided biopsy was consistent with a pheochromocytoma, although prior studies were negative. Finally, we present a 49-yr-old Caucasian woman who had a right adrenalectomy 10 yr prior and presented to the clinic with fluctuating blood pressures, headaches, and palpitations. Further testing revealed she had a recurrent metastatic pheochromocytoma. The challenges behind treating these patients are further explored.
CONCLUSION: Antenatal diagnosis of pheochromocytoma, though challenging, is associated with lower maternal and fetal morbidity and mortality. The differential diagnosis for cardiac arrest in the presence of normal coronary arteries should include a pheochromocytoma. Finally, treatment with iodinated metaiodobenzylguanidine may be a therapeutic option for those patients with metastatic pheochromocytomas.

Entities:  

Mesh:

Year:  2008        PMID: 18560264     DOI: 10.1007/BF03346390

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  30 in total

Review 1.  Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor.

Authors:  Elisabeth Edström Elder; Grahame Elder; Catharina Larsson
Journal:  J Surg Oncol       Date:  2005-03-01       Impact factor: 3.454

2.  [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.

Authors:  E van der Harst; W W de Herder ; H A Bruining; H J Bonjer; R R de Krijger ; S W Lamberts; A H van de Meiracker ; F Boomsma; T Stijnen; E P Krenning; F T Bosman; D J Kwekkeboom
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

3.  Biochemical diagnosis of pheochromocytoma: which test is best?

Authors:  Jacques W M Lenders; Karel Pacak; McClellan M Walther; W Marston Linehan; Massimo Mannelli; Peter Friberg; Harry R Keiser; David S Goldstein; Graeme Eisenhofer
Journal:  JAMA       Date:  2002-03-20       Impact factor: 56.272

4.  Pheochromocytoma and pregnancy. Review of 89 cases.

Authors:  J G Schenker; I Chowers
Journal:  Obstet Gynecol Surv       Date:  1971-11       Impact factor: 2.347

5.  Pheochromocytoma storm presenting as cardiovascular collapse at term pregnancy.

Authors:  Alexander Langerman; John A Schneider; R Parker Ward
Journal:  Rev Cardiovasc Med       Date:  2004       Impact factor: 2.930

6.  A diagnostic dilemma in diagnosing and managing an incidental phaeochromocytoma.

Authors:  A A Tahrani; A F Macleod
Journal:  Exp Clin Endocrinol Diabetes       Date:  2006-04       Impact factor: 2.949

7.  Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.

Authors:  Karel Pacak; Graeme Eisenhofer; Håkan Ahlman; Stefan R Bornstein; Anne-Paule Gimenez-Roqueplo; Ashley B Grossman; Noriko Kimura; Massimo Mannelli; Anne Marie McNicol; Arthur S Tischler
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-02

8.  Adrenal incidentaloma: review of 197 patients and report of a drug-related false-positive urinary normetanephrine result.

Authors:  Takahiro Ito; Tsuneo Imai; Toyone Kikumori; Arihiro Shibata; Takao Horiba; Hironobu Kobayashi; Masataka Sawaki; Reiko Watanabe; Akimasa Nakao; Tetsuya Kiuchi
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

9.  Pheochromocytoma and pregnancy: a case report and review of anesthetic management.

Authors:  Geoff Dugas; John Fuller; Sudha Singh; James Watson
Journal:  Can J Anaesth       Date:  2004-02       Impact factor: 5.063

10.  PC12 variants deficient in norepinephrine transporter mRNA have wild type activities of several other related transporters.

Authors:  K Houben; K Dardashti; B D Howard
Journal:  Neurochem Res       Date:  1994-06       Impact factor: 3.996

View more
  3 in total

1.  Phospho-mTOR is not upregulated in metastatic SDHB paragangliomas.

Authors:  Hans K Ghayee; Alessio Giubellino; Arielle Click; Payal Kapur; Alana Christie; Xian-Jin Xie; Victoria Martucci; Jerry W Shay; Rhonda F Souza; Karel Pacak
Journal:  Eur J Clin Invest       Date:  2013-07-26       Impact factor: 4.686

2.  Laparoscopic adrenalectomy for nonfamilial adrenal medullary hyperplasia.

Authors:  Miguel Ruiz Marín; Maria Fe Candel Arenas; Francisco Miguel González Valverde; Emilio Terol Garaulet; María Maestre Maderuelo; Amparo Meoro Avilés; Francisco Pastor Quirante; Antonio Albarracín Marín Blázquez
Journal:  JSLS       Date:  2013 Jul-Sep       Impact factor: 2.172

3.  Progenitor cell line (hPheo1) derived from a human pheochromocytoma tumor.

Authors:  Hans K Ghayee; Vikash J Bhagwandin; Victor Stastny; Arielle Click; Liang-Hao Ding; Dario Mizrachi; Ying S Zou; Raj Chari; Wan L Lam; Robert M Bachoo; Alice L Smith; Michael D Story; Stan Sidhu; Bruce G Robinson; Fiemu E Nwariaku; Adi F Gazdar; Richard J Auchus; Jerry W Shay
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.